Difference between revisions of "Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5 (Q9823)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 42, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: Page(s) (P105): 2530-2538, #quickstatements; #temporary_batch_1590074839150)
 
(One intermediate revision by the same user not shown)
Property / title
 +
A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English)
Property / title: A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English) / rank
 +
Normal rank
Property / Page(s)
 +
2530-2538
Property / Page(s): 2530-2538 / rank
 +
Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Oberneder R
    0 references
    0 references
    2006
    0 references
    Eur. J. Cancer
    0 references
    42
    0 references
    A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English)
    0 references
    2530-2538
    0 references